AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 267: F783-F790, 1994;
0363-6127/94 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Munger, K. A.
Right arrow Articles by Jackson, E. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Munger, K. A.
Right arrow Articles by Jackson, E. K.

AJP - Renal Physiology, Vol 267, Issue 5 783-F790, Copyright © 1994 by American Physiological Society

ARTICLES

Effects of selective A1 receptor blockade on glomerular hemodynamics: involvement of renin-angiotensin system

K. A. Munger and E. K. Jackson
Department of Medicine, Emory University School of Medicine, Atlanta, Georgia 30022.

We examined the renal effects of a specific adenosine A1-receptor antagonist, 1,3-dipropyl-8-cyclopentylxanthine (DPCPX, 10 micrograms.kg-1.min-1 iv). Since adenosine is a potent inhibitor of renin release, additional experiments were performed with an angiotensin AT1-receptor antagonist (losartan, 10 mg/kg i.v.). DP CPX alone induced a significant (P < 0.05) decrease in afferent arteriolar resistance (RA, 1.83 +/- 0.18 to 1.43 +/- 0.06 dyn.s.cm-5 x 10(10); P < 0.05). This led to a rise in the transcapillary hydraulic pressure difference (delta P, 35 +/- 1 to 43 +/- 2 mmHg; P < 0.05). Surprisingly, the glomerular capillary ultrafiltration coefficient (Kf) fell (0.101 +/- 0.017 to 0.064 +/- 0.009 nl.s-1.mmHg-1, P < 0.05). Additionally, DPCPX infusion resulted in dramatic increases in both urine flow and sodium excretion. With losartan pretreatment, DPCPX did not cause significant changes in RA and delta P. Also, DPCPX increased Kf (0.057 +/- 0.005 to 0.075 +/- 0.008 nl.s-1.mmHg-1, P < 0.05). Furthermore, the large DPCPX-induced increases in urine flow and sodium excretion were largely suppressed by pretreatment with losartan. These data indicate that endogenous adenosine plays a significant role in maintaining afferent arteriolar tone and that the renin-angiotensin system may mediate some of the wide ranging renal effects of adenosine.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
R. Gu, J. Wang, Y. Zhang, W. Li, Y. Xu, H. Shan, W.-H. Wang, and B. Yang
Adenosine stimulates the basolateral 50 pS K channels in the thick ascending limb of the rat kidney
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F299 - F305.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
V. Vallon, B. Muhlbauer, and H. Osswald
Adenosine and kidney function.
Physiol Rev, July 1, 2006; 86(3): 901 - 940.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
P. B. Hansen and J. Schnermann
Vasoconstrictor and vasodilator effects of adenosine in the kidney
Am J Physiol Renal Physiol, October 1, 2003; 285(4): F590 - F599.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
Y. Aki, A. Nishiyama, A. Miyatake, S. Kimura, M. Kohno, and Y. Abe
Role of Adenosine A1 Receptor in Angiotensin II- and Norepinephrine-Induced Renal Vasoconstriction
J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 117 - 123.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
E. K. Jackson, C. Zhu, and S. P. Tofovic
Expression of adenosine receptors in the preglomerular microcirculation
Am J Physiol Renal Physiol, July 1, 2002; 283(1): F41 - F51.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
E. K. Jackson and R. K. Dubey
Role of the extracellular cAMP-adenosine pathway in renal physiology
Am J Physiol Renal Physiol, October 1, 2001; 281(4): F597 - F612.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
A. Nishiyama, E. W. Inscho, and L. G. Navar
Interactions of adenosine A1 and A2a receptors on renal microvascular reactivity
Am J Physiol Renal Physiol, March 1, 2001; 280(3): F406 - F414.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
A. Nishiyama, S. Kimura, H. He, K. Miura, M. Rahman, Y. Fujisawa, T. Fukui, and Y. Abe
Renal interstitial adenosine metabolism during ischemia in dogs
Am J Physiol Renal Physiol, February 1, 2001; 280(2): F231 - F238.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
E. K. Jackson and Z. Mi
Preglomerular Microcirculation Expresses the cAMP-Adenosine Pathway
J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 23 - 28.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
C. K. Kost Jr., W. A. Herzer, B. R. Rominski, Z. Mi, and E. K. Jackson
Diuretic Response to Adenosine A1 Receptor Blockade in Normotensive and Spontaneously Hypertensive Rats: Role of Pertussis Toxin-Sensitive G-Proteins
J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 752 - 760.
[Abstract] [Full Text]

Home page
 J. Am. Soc. Nephrol.Home page
C. S. WILCOX, W. J. WELCH, G. F. SCHREINER, and L. BELARDINELLI
Natriuretic and Diuretic Actions of a Highly Selective Adenosine A1 Receptor Antagonist
J. Am. Soc. Nephrol., April 1, 1999; 10(4): 714 - 720.
[Abstract] [Full Text]

Home page
 Pharmacol. Rev.Home page
V. Ralevic and G. Burnstock
Receptors for Purines and Pyrimidines
Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online